Propylisopropyltryptamine

Propylisopropyltryptamine (PiPT) is a chemical in the tryptamine family, which reportedly produces psychedelic and hallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives,^[1] although PiPT is reportedly relatively weak and short lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.^[2]

Propylisopropyltryptamine

Clinical data
ATC code	none
Identifiers
IUPAC name [2-(1H-indol-3-yl)ethyl]-N-propyl-N-isopropylamine
CAS Number	1354632-00-0 N
PubChem CID	57464898
ChemSpider	21106369 Y
UNII	Q2Y9D5Q4T4
CompTox Dashboard (EPA)	DTXSID20726699
Chemical and physical data
Formula	C16H24N2
Molar mass	244.382 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)N(CCC)CCc2c[nH]c1ccccc12
InChI InChI=1S/C16H24N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h5-8,12-13,17H,4,9-11H2,1-3H3 Y Key:OFXPLOPRCQJJFP-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Chemistry

PiPT is short for N-propyl-N-isopropyl-tryptamine. PiPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines. PiPT is closely related to the compounds DPT and DiPT.

Dosage

PiPT is reported as being active at doses of 50-100mg orally, or 25mg smoked.^{[citation needed]}

Effects

Very little is known about the psychopharmacological properties of PiPT, but reports suggest it produces psychedelic effects similar to those of other hallucinogenic tryptamine derivatives, that can last around 2-4 hours.^{[citation needed]}

Dangers

There have been no reported deaths or hospitalizations from PiPT, but its safety profile is unknown.^{[citation needed]}

Legality

PiPT is unscheduled and uncontrolled in the United States, but possession and sales of PiPT could be prosecuted under the Federal Analog Act because of its structural similarities to other hallucinogenic tryptamine derivatives.

See also

• N,N-Dimethyltryptamine
• α-Methyltryptamine